HIMSS Awards Cambridge University Hospitals Stage 6 Status of the International Electronic Medical Record Adoption Model

HIMSS UKHealthcare Information and Management Systems Society has awarded Cambridge University Hospitals (CUH) with Stage 6 of the international Electronic Medical Record Adoption Model (EMRAM). The Healthcare Information and Management Systems Society (HIMSS) is an international organisation dedicated to improving healthcare quality, safety, cost-effectiveness and access, through the best use of IT. It developed an Electronic Medical Record Adoption Model (EMRAM) in 2005, which measures progress and the cumulative capabilities of Electronic Medical Record (EMR) systems within hospitals all over the world. Hospitals that reach Stage 6 (Stage 7 being the highest) have established clear goals for improving safety, minimising errors, and recognising the importance of healthcare IT.

This accreditation, which is the only international standard that recognises the effective use of technology in delivering high quality patient care, was validated following an onsite visit by Healthcare Information and Management Systems Society (HIMSS).

HIMSS inspectors visited CUH to assess the use and adoption of its new Epic electronic patient record (EPR) system, which went live on 26 October 2014 across both of its hospitals - Addenbrooke's and the Rosie. As part of the day-long assessment, inspectors spent time with clinical and administrative staff working in paediatrics, pharmacy, radiology, ICU, the emergency department and medical records, observing the delivery of high quality patient care with the use of a fully integrated EPR.

Effective use of the EPR system was showcased including the delivery of closed loop medication to auto identify the nurse, the patient and the medication; increased patient safety and medication error awareness; and many processes now being paperless due to the implementation of the system.

John Rayner, Director of Professional Development at HIMSS Europe, added: "The distance that the Trust has travelled in such a short period of time really stood out during the site visit. To be awarded a Stage 6 validation in less than 12 months of being live with the new system is quite commendable and a real credit to all concerned. We look forward to working with the trust in the future and will observe their progress with considerable interest."

About HIMSS Analytics in Europe
HIMSS Analytics in Europe provides healthcare organisations, governments and industry with extensive data resources and services about the adoption and use of healthcare IT in Europe. HIMSS Analytics' offerings include database and advisory solutions which encompass market research, IT adoption benchmarking, IT Maturity Models for topics like Electronic Medical Records or Continuity of Care. These offerings are designed to support Management and CIOs, IT Executives and Clinicians from across Europe to compare and measure their progress.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...